Explore the latest on-demand video content in Campus Sanofi
Panel Discussion on Vaccination and the Philippine Health Systems – Understanding Challenges, Creating Opportunities
Influenza Vaccination After Myocardial Infarction (IAMI)
Are you aware that contracting the flu may heighten your chances of experiencing a heart attack? Studies indicate that those who catch influenza are at a higher risk for cardiovascular events. Fortunately, clinical research has shown that receiving the influenza vaccine can decrease the likelihood of such events, particularly in patients with existing heart conditions. (1) Click on the video to find out more.
1. Frøbert O et al. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial,Circulation. 2021 doi:10.1161/CIRCULATIONAHA.121.057042
Impact of Flu on Cardio
This is no coincidence: Influenza has been identified as a trigger for cardiovascular events. It can be much more dangerous than one would think.(1) How does influenza lead to an increase of cardiovascular events? Click on the video to understand the possible mechanisms behind the risk.
Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. The Lancet Infectious diseases. 2009;9(10):601-10.
Protection Beyond Flu
Influenza is a devastating and unpredictable disease. A new standard is required. Protection Beyond Flu is Sanofi’s commitment to ensuring people have access to influenza vaccines with proven better protection against flu infection and its severe outcomes. Share these standards? Watch to find out more.
Renal VOD - Serum Phosphorus in CKD
For a closer look at the role of phosphorus in chronic kidney disease, join Dr. Marissa Lim, an internal medicine and adult kidney specialist, as she discusses hyperphosphatemia in chronic kidney disease patients and expounds on the clinical impact of the disease, its management, as well as possible treatment options available for it.
Listen to select on-demand podcasts in Campus Sanofi
ZENTV Episode 01
Join Dr. Al Fazir Omar, a Cardiologist from Malaysia and one of the members of the Expert Panel of the Malaysian Clinical Practice Guidelines on the Management of Dyslipidemia (2017) as he discusses some ways to optimize dyslipidemia management and the role of combination therapy.
In this episode of Heartbeats VOD, join Cardiologists; Dr. Rodney Jimenez from St. Luke’s Medical Center and Dr. Luigi Segundo from The Medical City as they discuss ACS management for a STEMI patient.
Medically Ill patients at risk for VTE
In this episode of Heartbeats VOD, join Dr. Jude Erric Cinco, President of Philippine Heart Association and Dr. Luigi Segundo, a Cardiologist from The Medical City, as they share their perspectives on VTE, risk stratification and a clinical perspective on how to manage medically ill patients at risk for VTE.
FDC in Hypertension Management
Join Dr. Nannette Rey, Past President of the Philippine Heart Association and Dr. Amelita Brillantes, Cardiologist from Perpetual Help Medical Center Binan, as they discuss some studies on Fixed-Dose Combination (FDC) Therapy in the management of Hypertension and the latest hypertension guidelines that recommend the use of FDC therapy.
Hypertension and Diabetes
In this episode of Heartbeats VOD, join Dr. Sjoberg Kho, an Endocrinologist from USTH and Dr. Sonny Abrahan, a Cardiologist from PGH as they discuss the management of Hypertension in patients with Diabetes and the impact of an ARB, Irbesartan, on Renal disease in patients with Hypertension and Type 2 Diabetes.
Hypertension - Dyslipidemia
This video is a case discussion of a patient with Hypertension and Dyslipidemia with Dr. Deborah Ona, President of the Philippine Society of Hypertension and Dr. Sonny Abrahan, a Cardiologist from PGH.
Join them as they discuss the case while highlighting key points from 2020 Clinical Practice Guidelines for the Management of Hypertension in the Philippines.